Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
MARKER THERAPEUTICS, INC. (MRKR) had Return on Equity of -30.68% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.35M |
|
$-4.45M |
|
-- |
|
$0.35M |
|
$4.96M |
|
$-4.61M |
|
$0.16M |
|
$-4.45M |
|
$-4.45M |
|
$-4.45M |
|
$-4.45M |
|
$-4.45M |
|
$-4.45M |
|
$-4.61M |
|
$-4.61M |
|
11.11M |
|
11.11M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$16.99M |
|
-- |
|
-- |
|
$16.99M |
|
$2.50M |
|
-- |
|
-- |
|
$2.50M |
|
$14.49M |
|
$14.49M |
|
$14.49M |
|
11.20M |
|
| Cash Flow Statement Financials | |
$-5.50M |
|
-- |
|
$0.00M |
|
$19.19M |
|
$13.69M |
|
$-5.50M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.79 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
100.00% |
|
-1320.14% |
|
-1320.14% |
|
-- |
|
-1273.60% |
|
-1273.60% |
|
$-5.50M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.14 |
|
633.88 |
|
|
Return on Equity |
-30.68% |
-30.68% |
|
-26.16% |
|
-30.68% |
|
$1.29 |
|
$-0.50 |
|
$-0.50 |
|